With the deadline to implement the 2013 Drug Supply Chain Security Act (DSCSA) now less than two years away, HDA has released a new video that highlights the great progress that has been made by industry to implement DSCSA and some of the biggest challenges that still remain.
The two-year countdown to the Drug Supply Chain Security Act (DSCSA) deadline has begun. This final milestone, in combination with those already completed, will fundamentally change how product and data move together across the healthcare supply chain.
Since the Drug Supply Chain Security Act (DSCSA) was enacted nearly 10 years ago, healthcare supply chain stakeholders have made steady progress in meeting regularly (through HDA and other settings) to discuss compliance strategies, establish recommended guidelines and build consensus on key milestones.
Earlier this month, HDA published two new resources for supply chain stakeholders to ensure the proper handling of new products moving through the supply chain and removal of products that are recalled or need to be withdrawn.
HDA will be carrying forward the early lessons learned from COVID-19 pandemic and supporting response efforts in 2021, writes President and CEO Chip Davis in the January 4 issue of Chain Drug Review — particularly as distributors play a role in the largest public vaccination effort in recent memory. Davis provided his perspective on the year ahead, along with other healthcare trade association leaders, as part of the publication’s 2021 “Pharmacy Outlook” feature.